• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者随访期间可穿戴式心脏复律除颤器的远程监测潜力

Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure.

作者信息

Blockhaus Christian, Guelker Jan-Erik, Feyen Ludger, Bufe Alexander, Seyfarth Melchior, Shin Dong-In

机构信息

Heart Centre Niederrhein, Department of Cardiology, Helios Clinic Krefeld, 47805 Krefeld, Germany.

Faculty of Health, School of Medicine, University Witten/Herdecke, 58448 Witten, Germany.

出版信息

J Cardiovasc Dev Dis. 2022 Jun 1;9(6):175. doi: 10.3390/jcdd9060175.

DOI:10.3390/jcdd9060175
PMID:35735804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224944/
Abstract

BACKGROUND

Wearable cardioverter-defibrillators (WCDs) are a well-established tool to bridge the recovery time of left ventricular ejection fraction (LVEF) until the implantation of an implantable cardioverter defibrillator (ICD), as recommended by the current guidelines. Besides their function to detect and treat malignant arrhythmias, WCDs may be used as a telemonitoring system. In this study, we sought to illustrate and discuss the telemonitoring potential of WCDs and to analyze physical activity in specific patient cohorts.

METHODS AND RESULTS

We retrospectively included 140 patients with reduced LVEF who were prescribed WCDs in our clinic. We analyzed the patients' physical activity ( = 105 with a WCD compliance above 21 h/day), body position and resting position. We found a reduced physical activity in women and in patients over the age of 65 compared to younger patients. Furthermore, the patients who were overweight or obese showed significantly reduced physical activity compared to the patients with a normal weight (6365 ± 3572 vs. 4972 ± 2476 vs. 7045 ± 3521, = 0.02).

CONCLUSION

WCDs may be used as a telemonitoring and intervention tool in patients with reduced LVEF. Specific patient groups may benefit from guidance from their treating physician regarding physical activity.

摘要

背景

按照现行指南推荐,可穿戴式心脏复律除颤器(WCD)是一种成熟的工具,用于在植入植入式心脏复律除颤器(ICD)之前的左心室射血分数(LVEF)恢复期间发挥桥梁作用。除了检测和治疗恶性心律失常的功能外,WCD还可作为远程监测系统使用。在本研究中,我们试图阐述和讨论WCD的远程监测潜力,并分析特定患者群体的身体活动情况。

方法和结果

我们回顾性纳入了140例在我们诊所被处方使用WCD的LVEF降低的患者。我们分析了患者的身体活动(n = 105,WCD依从性高于每天21小时)、体位和静息位。我们发现,与年轻患者相比,女性和65岁以上患者的身体活动减少。此外,超重或肥胖患者的身体活动与体重正常的患者相比显著减少(6365±3572 vs. 4972±2476 vs. 7045±3521,P = 0.02)。

结论

WCD可作为LVEF降低患者的远程监测和干预工具。特定患者群体可能受益于治疗医师给予的关于身体活动的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/2b9b68587214/jcdd-09-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/bb1adbc0832d/jcdd-09-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/ec467e4b569e/jcdd-09-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/2b9b68587214/jcdd-09-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/bb1adbc0832d/jcdd-09-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/ec467e4b569e/jcdd-09-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ecc/9224944/2b9b68587214/jcdd-09-00175-g003.jpg

相似文献

1
Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure.心力衰竭患者随访期间可穿戴式心脏复律除颤器的远程监测潜力
J Cardiovasc Dev Dis. 2022 Jun 1;9(6):175. doi: 10.3390/jcdd9060175.
2
Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting.可穿戴式心脏复律除颤器在实际心力衰竭病房环境中用作远程监测系统。
J Clin Med. 2021 Nov 22;10(22):5435. doi: 10.3390/jcm10225435.
3
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.可穿戴式心脏复律除颤器支持的强化心力衰竭治疗优化以避免过早植入植入式心脏复律除颤器——PROLONG研究
J Am Heart Assoc. 2017 Jan 17;6(1):e004512. doi: 10.1161/JAHA.116.004512.
4
Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators.左束支传导阻滞和血尿素氮的缺失可预测植入式心律转复除颤器的心肌病患者左心室射血分数的改善。
Clin Cardiol. 2020 Mar;43(3):260-266. doi: 10.1002/clc.23295. Epub 2019 Dec 20.
5
Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.心力衰竭患者的治疗优化:可穿戴式心脏复律除颤器在实际应用中的作用。
BMC Cardiovasc Disord. 2018 Mar 15;18(1):52. doi: 10.1186/s12872-018-0790-8.
6
The Role of the Wearable Defibrillator in Heart Failure.可穿戴除颤器在心力衰竭中的作用。
Curr Heart Fail Rep. 2024 Feb;21(1):33-42. doi: 10.1007/s11897-023-00641-x. Epub 2024 Jan 18.
7
Single-center experience with wearable cardioverter-defibrillator as a bridge before definitive ICD implantation.单中心使用可穿戴式心脏复律除颤器作为植入确定性植入式心脏复律除颤器之前的过渡手段的经验。
Indian Pacing Electrophysiol J. 2020 Mar-Apr;20(2):60-63. doi: 10.1016/j.ipej.2019.12.010. Epub 2019 Dec 16.
8
The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.可穿戴式除颤器的使用对半农村地区急性护理医院植入心脏除颤器的长期决策的影响。
J Interv Card Electrophysiol. 2021 Nov;62(2):401-407. doi: 10.1007/s10840-020-00898-5. Epub 2020 Nov 17.
9
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
10
Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).晚期心力衰竭患者可穿戴式心脏复律除颤器研究(SWIFT)。
J Cardiovasc Electrophysiol. 2017 Jul;28(7):778-784. doi: 10.1111/jce.13229. Epub 2017 May 29.

引用本文的文献

1
Remote Monitoring of Patients with Heart Failure: Characteristics of Effective Programs and Implementation Strategies.心力衰竭患者的远程监测:有效方案的特点及实施策略
Vasc Health Risk Manag. 2025 Jun 25;21:489-503. doi: 10.2147/VHRM.S521952. eCollection 2025.
2
Adherence to eHealth Interventions Among Patients With Heart Failure: Scoping Review.心力衰竭患者对电子健康干预措施的依从性:范围综述
JMIR Mhealth Uhealth. 2025 Jun 27;13:e63409. doi: 10.2196/63409.
3
A scoping review on advancements in noninvasive wearable technology for heart failure management.

本文引用的文献

1
Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting.可穿戴式心脏复律除颤器在实际心力衰竭病房环境中用作远程监测系统。
J Clin Med. 2021 Nov 22;10(22):5435. doi: 10.3390/jcm10225435.
2
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
关于用于心力衰竭管理的无创可穿戴技术进展的范围综述。
NPJ Digit Med. 2024 Oct 12;7(1):279. doi: 10.1038/s41746-024-01268-5.
4
Appropriate use of wearable defibrillators with multiparametric evaluation to avoid unnecessary defibrillator implantation.恰当使用带有多参数评估的可穿戴除颤器,以避免不必要的除颤器植入。
Open Heart. 2024 Sep 18;11(2):e002787. doi: 10.1136/openhrt-2024-002787.
5
Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure.使用可穿戴式心脏复律除颤器评估新诊断心力衰竭患者的身体活动情况。
Front Cardiovasc Med. 2023 May 12;10:1176710. doi: 10.3389/fcvm.2023.1176710. eCollection 2023.
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
4
Heart Failure With Reduced Ejection Fraction: A Review.射血分数降低型心力衰竭:综述。
JAMA. 2020 Aug 4;324(5):488-504. doi: 10.1001/jama.2020.10262.
5
Association of Daily Step Count and Step Intensity With Mortality Among US Adults.美国成年人的日常步数和步频与死亡率的关系。
JAMA. 2020 Mar 24;323(12):1151-1160. doi: 10.1001/jama.2020.1382.
6
Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses.可穿戴式除颤器依从性对 VEST 试验结果的影响:按治疗分析和意向性分析。
J Cardiovasc Electrophysiol. 2020 May;31(5):1009-1018. doi: 10.1111/jce.14404. Epub 2020 Mar 3.
7
Physical Activity in Adults With Wearable Cardioverter Defibrillators in the Post-Myocardial Infarction Period.心梗后时期穿戴式心脏除颤器成人的身体活动。
J Cardiopulm Rehabil Prev. 2020 May;40(3):164-166. doi: 10.1097/HCR.0000000000000454.
8
Sex and Gender-Related Issues in Heart Failure.心力衰竭中的性别相关问题。
Heart Fail Clin. 2020 Jan;16(1):121-130. doi: 10.1016/j.hfc.2019.08.005.
9
Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator.在植入可穿戴式除颤器的患者中,室性心律失常发生前的身体活动减少。
Clin Cardiol. 2020 Jan;43(1):60-65. doi: 10.1002/clc.23288. Epub 2019 Nov 11.
10
Physical Activity and Sleep Analysis of Heart Failure Patients using Multi-sensor Patches.使用多传感器贴片对心力衰竭患者进行身体活动和睡眠分析。
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:6092-6095. doi: 10.1109/EMBC.2018.8513594.